JPRN-UMIN000006466招募中未知
Evaluation of molecular imaging of DNA synthesis for diagnosis, theraputic value and recurrent diagnosis of head and neck tumor - 4'-[methyl-11C]thiotymidine(4DST)PET for head and neck carcinoma diagnosis
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1.Pregnancy or lactating womem, or women with suspected pregnancy. 2.Patient with severe underlying disease having risk of liver dysfunction, renal dysfunction and any metabolic damage. 3.Just after surgery and/or trauma. 4.Poor controled diabetics. 5.Anaphylaxis of thiotymidine or tymidine. 6.Those who are determined as not appropriate for the study by physician in chief.
研究者
相似试验
已完成
不适用
Molecular imaging of DNA synthesis using a new PET tracer: clinical study of diagnosis for cardiac sarcoidosisCardiac sarcoidosisJPRN-UMIN000030642ational Center for Global Health and Medicine95
已完成
2 期
Molecular imaging of DNA synthesis using a new PET tracer: clinical study of diagnosis and therapeutic assessment for esophageal cancerEsophageal cancerJPRN-UMIN000018058ational Center for Global Health and Medicine50
进行中（未招募）
1 期
Study to demonstrate an at least equivalent performance of a new test in brain imaging test compared to the reference examination to establish the differential diagnosis between Parkinson's Disease and Essential Tremor.Patients suffering from an essential tremor or with Parkinson's disease.MedDRA version: 20.0Level: PTClassification code 10061536Term: Parkinson's diseaseSystem Organ Class: 10029205 - Nervous system disordersMedDRA version: 20.0Level: PTClassification code 10015496Term: Essential tremorSystem Organ Class: 10029205 - Nervous system disordersEUCTR2019-000247-27-FRZIONEXA112
已完成
不适用
ProMOTE EMI-137: Prostate Molecular Targeting to Enhance surgery using EMI-137Prostate cancerCancerISRCTN97555789niversity of Oxford2
进行中（未招募）
不适用
Prospective evaluation of image and molecular fingerprint characterization to guide treatment with tyrosine kinase inhibitors in hepatocellular carcinomaC22.0Liver cell carcinomaDRKS00015917niversitätsklinikum Tübingen2